GlassScriptPhysician profile
Bilal Siddiqui
NPI 1780971523
$5,922.99
in general payments reported to CMS, 2019-2025
28 companies · $616 in 2025
The $616 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $759 · 2021: $1,762 · 2022: $609 · 2023: $609 · 2024: $1,044 · 2025: $616.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,269.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,415.77 | 2019-2025 | Ortholoc 3di, Actishield Cf, Augment Injectable |
| Medwest Associates | $1,230.84 | 2021 | |
| Smith+Nephew, INC. | $1,138.98 | 2020-2024 | Grafix Pl, Stravix Pl, Grafix |
| Organogenesis INC. | $207.53 | 2022-2023 | Puraply |
| Wright Medical Technology, INC. | $200.26 | 2019-2020 | |
| Alafair Biosciences, INC. | $177.25 | 2024 | Versawrap |
| Bioventus LLC | $172.65 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Treace Medical Concepts, INC. | $169.22 | 2023-2025 | |
| Orthofix Medical, INC. | $129.23 | 2020-2024 | Physio-Stim |
| Pacira Pharmaceuticals Incorporated | $123.63 | 2025 | Exparel |
| Depuy Synthes Sales INC. | $116.32 | 2024-2025 | Dynacord, Gryphon Orthocord, Quickanchor Orthocord |
| Integra Lifesciences Corporation | $105.80 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Acumed LLC | $97.15 | 2023 | Osteomed, 2.0 Mm Inion Otps, Acumed |
| Fusion Orthopedics USA, LLC | $93.78 | 2024 | |
| Zimmer Biomet Holdings, INC. | $91.94 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $75.00 | 2025 | Venaseal |
| Paragon 28, INC. | $58.91 | 2023-2025 | Tenotac, Activcore Nail |
| Horizon Therapeutics Plc | $43.30 | 2019-2022 | |
| Amgen INC. | $42.15 | 2025 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $41.14 | 2024-2025 | Nuzyra |
| Abbott Laboratories | $35.56 | 2023-2024 | Eterna, Axium |
| Glaxosmithkline, LLC. | $33.27 | 2020 | |
| Kerecis Limited | $31.40 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Mimedx Group, INC. | $26.30 | 2025 | |
| Cashflow Solutions, LLC | $20.98 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Bone Support INC. | $19.11 | 2025 | Ceramentbone Void Filler, Cerament G |
| Acera Surgical, INC. | $13.69 | 2024 | Restrata Wound Matrix |
| Osiris Therapeutics INC. | $11.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bilal Siddiqui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.